title: An overview of the antiretroviral market.
abstract: OBJECTIVE
  An understanding of the current state of the antiretroviral marketplace is an important context in which to consider drug optimization work.
  
  
  RESULTS
  The antiretroviral marketplace has undergone a remarkable evolution over the past 11 years, expanding from serving less than 300 000 patients in low and middle-income countries in 2002 to almost 10 million patients today. In addition to dramatic growth, a steady and rapid improvement in the drugs and drug regimens used to treat patients has characterized a rapidly changing market.
  
  
  CONCLUSIONS
  The antiretroviral marketplace has been characterized by rapid growth and a succession of improving drugs and regimens over the past 11 years. The dynamic and innovative marketplace provides a strong platform from which to introduce new, optimized drugs and regimens to better serve patients' health needs.
authors.affiliation: Clinton Health Access Initiative, Boston, Massachusetts, USA.
authors.forename: Geannan
authors.initials: G
authors.lastname: Camponeschi
authors.forename: Jessica
authors.initials: J
authors.lastname: Fast
authors.forename: Marianne
authors.initials: M
authors.lastname: Gauval
authors.forename: Katherine
authors.initials: K
authors.lastname: Guerra
authors.forename: Meredith
authors.initials: M
authors.lastname: Moore
authors.forename: Siddharth
authors.initials: S
authors.lastname: Ravinutala
authors.forename: David
authors.initials: D
authors.lastname: Ripin
authors.forename: Vadim
authors.initials: V
authors.lastname: Shepel
mesh_terms: D044966:Anti-Retroviral Agents / Q000191:economics* / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics* / Q000379:methods*; D019981:Health Care Sector / Q000639:trends*; D006801:Humans
chemical_list: D044966:Anti-Retroviral Agents